I. Chen

发表

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

Andrew H. Beck, Jacqueline A. Hall, Sarah N. Dudgeon, 2020, npj Breast Cancer.

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

Jacqueline A. Hall, Sarah N. Dudgeon, A. Gown, 2020, npj Breast Cancer.

Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients.

I. Chen, Chiun Hsu, K. Yeh, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era

Chiun-Sheng Huang, I. Chen, H. Lien, 2011, Breast Cancer Research and Treatment.

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Andrew H. Beck, Jacqueline A. Hall, Sarah N. Dudgeon, 2020, npj Breast Cancer.

High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country

Jih-Hsiang Lee, Chien-Jen Chen, Chen-Yang Shen, 2015, PloS one.

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Andrew H. Beck, Jacqueline A. Hall, A. Beck, 2020, npj Breast Cancer.

PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study.

I. Chen, Yen-Shen Lu, Ming-Han Yang, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival

I. Chen, T. Chen, A. Cheng, 2020, Journal of Neuro-Oncology.

Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers

I. Chen, Chiun Hsu, J. Yang, 2014, Supportive Care in Cancer.

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

E. Perez, C. Sotiriou, S. Loi, 2021, NPJ breast cancer.

Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer

Chen-Yang Shen, Chiun-Sheng Huang, I. Chen, 2016, Scientific Reports.

Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma

Chiun-Sheng Huang, I. Chen, H. Lien, 2023, Breast Cancer Research.

The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

A. Gown, T. Nielsen, E. Thompson, 2020, The Journal of pathology.

Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic components

I. Chen, H. Lien, T. Chen, 2020, Virchows Archiv.

Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen

I. Chen, Li-Ping Hsiao, A. Cheng, 2017, Scientific Reports.

5097 Poor response to systemic chemotherapy in metaplastic carcinoma of breast

Yiling Lu, I. Chen, A. Cheng, 2009 .

Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients.

I. Chen, K. Yeh, F. Hu, 2013 .

Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients

I. Chen, A. Cheng, Ching-Hung Lin, 2021, Breast.

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

Andrew H. Beck, Clare C. Yu, M. N. Vidya, 2021, npj Breast Cancer.

Adiposity, Inflammation, and Breast Cancer Pathogenesis in Asian Women

C. Hudis, I. Chen, A. Dannenberg, 2017, Cancer Prevention Research.

Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis.

I. Chen, A. Cheng, Ching-Hung Lin, 2016, Journal of the Formosan Medical Association = Taiwan yi zhi.

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

Jacqueline A. Hall, Sarah N. Dudgeon, A. Gown, 2020, npj Breast Cancer.

High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia

R. Huang, J. Thiery, Chiun-Sheng Huang, 2021, npj Breast Cancer.

High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia

R. Huang, J. Thiery, Chiun-Sheng Huang, 2021, NPJ breast cancer.

Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian versus Western Populations.

Chiun-Sheng Huang, I. Chen, W. Kuo, 2019, The oncologist.

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.

Sarah N. Dudgeon, A. Beck, T. Nielsen, 2020, NPJ breast cancer.

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer

I. Chen, T. Chen, Wen-Shuo Hsiao, 2023, Breast Cancer Research and Treatment.

Significant Clinical Factors Associated with Long-term Mortality in Critical Cancer Patients Requiring Prolonged Mechanical Ventilation

J. Shih, I. Chen, Yen-Fu Chen, 2017, Scientific Reports.

Anti-tumor efficacy of a bevacizumab preconditioning followed by etoposide and cisplatin regimen in human epidermal growth factor receptor-2-positive breast cancer brain metastasis refractory to whole brain radiotherapy

K. Rau, I. Chen, T. Chen, 2023, Journal of Cancer Research and Practice.

Lifestyle Factors and Energy Intakes with Risks of Breast Cancer among Pre- and Post- Menopausal Women in Taiwan

I. Chen, Chiao-I Chang, L. Tsai, 2023, Nutrients.

Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis

I. Chen, T. Chen, Ching-Hung Lin, 2023, Cancer medicine.

Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen

I. Chen, Li-Ping Hsiao, A. Cheng, 2017, Scientific Reports.

Quantifying payloads of antibody‒drug conjugates using a postcolumn infused-internal standard strategy with LC‒MS.

I. Chen, Chih-Ning Cheng, Ching-Hung Lin, 2024, Analytica chimica acta.

Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis

I. Chen, Ching-Hung Lin, D. Chang, 2024, Cancer medicine.

Characteristics and transcriptional regulators of spontaneous epithelial–mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma

I. Chen, H. Lien, Li-Ping Hsiao, 2024, Breast cancer research : BCR.